Concentrix Corporation (CNXC) Stock Analysis 2026

TechnologyInformation Technology Services
$29.27
as of 2026-09-14
-47.4% (52-week)50D MA $24.91  |  200D MA $30.67

BriMind AI Score

Proprietary
24
Weak
Price CAGR
-16.4%
1Y Return
-47.7%
Analyst Upside
+24.8%
Rev Growth
1.9%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$25.31-13.5% potential
Bear Case
$17.33
Bull Case
$41.76
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

CNXC Revenue & Profitability Breakdown

This chart shows how CNXC's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$10.00B
Cost of Revenue
-$6.55B
Gross Profit
$3.45B34.5% margin
Operating Expenses
-$2.66B
Operating Income
$789.2M7.9% margin
Tax & Other
-$2.10B
Net Income
-$-1.31B-13.1% margin
Gross Margin
34.5%
Operating Margin
7.9%
Net Margin
-13.1%

Key Financial Metrics

Concentrix Corporation doesn't carry a meaningful trailing P/E right now, generates $775.6M in free cash flow, runs a debt/equity ratio of 203.76, and converts shareholder equity into profit at a -37.7% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$1.98B
P/E (Forward)
2.73
PEG Ratio
0.41
Price / Book
0.73
Revenue
$10.00B
Revenue Growth
1.9%
Earnings Growth
36.1%
EPS (Trailing)
$-20.84
EPS (Forward)
$11.89
Gross Margin
34.5%
Operating Margin
7.9%
Net Margin
-13.1%
Return on Equity
-37.7%
Return on Assets
3.4%
Free Cash Flow
$775.6M
Debt / Equity
203.76
Current Ratio
1.18
Quick Ratio
0.87
Beta
0.42
Dividend Yield
4.5%
Payout Ratio
28.2%
Insider Ownership
17.5%
Inst. Ownership
115.1%
Short % Float
20.4%
Book Value / Share
$44.38

Wall Street Analyst Consensus

Wall Street analysts covering Concentrix Corporation currently haven't converged on a clear consensus rating, with a mean 12-month price target of $35.25 (+20.4% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Mean Target$35.25+20.4% upside

Intrinsic Value Estimates for CNXC

We use 1 valuation model to estimate CNXC's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

P/E Based (15× forward)
$178.35
+509.3% vs current
Multiplies next year's estimated earnings per share by 15×. More forward-looking; useful for high-growth companies where current earnings understate potential.
Fair Value Range
$178.35 – $178.35
Average Estimate
$178.35
Potential Upside
509.3%

Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Technical Price Signals

CNXC is currently in a short-term uptrend, trading above its 50-day average of $24.91 and below its 200-day average of $30.67. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

Current Price
$29.27
50-Day MA
$24.91
▲ Price above
200-Day MA
$30.67
▼ Price below
Short-term Uptrend
Above 50-day MA but mixed longer-term

Unlock the Full CNXC Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis